Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Obesity and weight management for the prevention and treatment of diabetes: standards of Care in Diabetes-2026
Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
Reviews Endocrinol
The Link Between Mounjaro and Diabetic Retinopathy: What the Evidence Shows Risk Factors and Monitoring Recommendations for Patients on Mounjaro Clinical Guidance: When to Seek Ophthalmology Review Frequently Asked Questions About Mounjaro and Eye Health Scientific References Frequently Asked Questions Understanding Mounjaro (Tirzepatide) and Its Use in Diabetes Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for adults with type 2 diabetes
US$ 24.39
US$ 23.93
US$ 28.06
US$ 22.35
